deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet Respir Med. 2017 Sep;5(9):691-706. \[[PMC free article: PMC5573769](/pmc/articles/PMC5573769/)\] \[[PubMed: 28822787](https://pubmed.ncbi.nlm.nih.gov/28822787)\] 3. Stockley RA. Neutrophils and protease/antiprotease imbalance. Am J Respir Crit Care Med. 1999 Nov;160(5 Pt 2):S49-52. \[[PubMed: 10556170](https://pubmed.ncbi.nlm.nih.gov/10556170)\] 4. Parker CM, Voduc N, Aaron SD, Webb KA, O'Donnell DE. Physiological changes during symptom recovery from moderate exacerbations of COPD. Eur Respir J. 2005 Sep;26(3):420-8. \[[PubMed: 16135722](https://pubmed.ncbi.nlm.nih.gov/16135722)\] 5. Mattos WL, Signori LG, Borges FK, Bergamin JA, Machado V. Accuracy of clinical examination findings in the diagnosis of COPD. J Bras Pneumol. 2009 May;35(5):404-8. \[[PubMed: 19547847](https://pubmed.ncbi.nlm.nih.gov/19547847)\] 6. Changizi M, Rio K. Harnessing color vision for visual oximetry in central cyanosis. Med Hypotheses. 2010 Jan;74(1):87-91. \[[PubMed: 19699589](https://pubmed.ncbi.nlm.nih.gov/19699589)\] 7. Qaseem A, Wilt TJ, Weinberger SE, Hanania NA, Criner G, van der Molen T, Marciniuk DD, Denberg T, Sch√ºnemann H, Wedzicha W, MacDonald R, Shekelle P., American College of Physicians. American College of Chest Physicians. American Thoracic Society. European Respiratory Society. Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory Society. Ann Intern Med. 2011 Aug 02;155(3):179-91. \[[PubMed: 21810710](https://pubmed.ncbi.nlm.nih.gov/21810710)\] 8. Decramer M, Janssens W, Miravitlles M. Chronic obstructive pulmonary disease. Lancet. 2012 Apr 07;379(9823):1341-51. \[[PMC free article: PMC7172377](/pmc/articles/PMC7172377/)\] \[[PubMed: 22314182](https://pubmed.ncbi.nlm.nih.gov/22314182)\] 9. FLETCHER CM, ELMES PC, FAIRBAIRN AS, WOOD CH. The significance of respiratory symptoms and the diagnosis of chronic bronchitis in a working population. Br Med J. 1959 Aug 29;2(5147):257-66. \[[PMC free article: PMC1990153](/pmc/articles/PMC1990153/)\] \[[PubMed: 13823475](https://pubmed.ncbi.nlm.nih.gov/13823475)\] 10. ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med. 2002 Jul 01;166(1):111-7. \[[PubMed: 12091180](https://pubmed.ncbi.nlm.nih.gov/12091180)\] 11. Shaker SB, Dirksen A, Bach KS, Mortensen J. Imaging in chronic obstructive pulmonary disease. COPD. 2007 Jun;4(2):143-61. \[[PubMed: 17530508](https://pubmed.ncbi.nlm.nih.gov/17530508)\] 12. Anthonisen NR, Manfreda J, Warren CP, Hershfield ES, Harding GK, Nelson NA. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med. 1987 Feb;106(2):196-204. \[[PubMed: 3492164](https://pubmed.ncbi.nlm.nih.gov/3492164)\] 13. Melani AS. Long-acting muscarinic antagonists. Expert Rev Clin Pharmacol. 2015;8(4):479-501. \[[PubMed: 26109098](https://pubmed.ncbi.nlm.nih.gov/26109098)\] 14. Ram FS, Jones PW, Castro AA, De Brito JA, Atallah AN, Lacasse Y, Mazzini R, Goldstein R, Cendon S. Oral theophylline for chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2002;2002(4):CD003902. \[[PMC free